The company is now hoping for an affirmative answer on its application after an unusually turbulent year dealing with U.S.
Wall Street analysts believe that a more cautious approach to manufacturing, study enrollment and side effect management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results